RxDoctor Payments Data

Gary Rubin

Medical · Rockledge, FLNPI 1629167630

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,676,255 of the $2,113,639 with a category attached, or 79.3%. AbbVie accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $516,210, 2.7 times the $189,644 reported in 2021. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,113,639in general payments, 2019–2025

Across 2,383 payments — averaging $886.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2.1M
  • Galderma Laboratories, L.p.$168
  • Revance Therapeutics, Inc.$19

What the payments were for

  • Consulting fees$130,4366%
  • Speaking & faculty fees$1,676,25579%
  • Travel & lodging$257,47512%
  • Food & beverage$49,2762%
  • Education$1960%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)2,380$2,113,452
Galderma Laboratories, L.p.2$168
Revance Therapeutics, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,113,639 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida →

Other medical in Rockledge

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →